Protocolised Management In Sepsis (ProMISe): a multicentre, randomised controlled trial of the clinical and cost-effectiveness of early protocolised resuscitation for emerging septic shock

Mouncey?P R; Osborn?T M; Power?G S; Harrison?D A; Sadique?M Z; Grieve?R D; Jahan?R; Tan?J C; Harvey?S E; Bell?D; Bion?J F; Coats?T J; Singer?M; Young?J D; Rowan?K M

首页> 外文期刊>Health technology assessment: HTA >Protocolised Management In Sepsis (ProMISe): a multicentre, randomised controlled trial of the clinical and cost-effectiveness of early protocolised resuscitation for emerging septic shock

【24h】

Protocolised Management In Sepsis (ProMISe): a multicentre, randomised controlled trial of the clinical and cost-effectiveness of early protocolised resuscitation for emerging septic shock

机译：脓毒症的规范化管理（ProMISe）：一项多中心，随机对照试验，针对新兴脓毒性休克的早期规范化复苏的临床和成本效益

获取原文

掌桥外文数据库（机构版） >>

开具论文收录证明 >>

页面导航

著录项
相似文献
相关主题

著录项

来源
《Health technology assessment: HTA》 |2015年第97期|共页
作者
Mouncey?P R; Osborn?T M; Power?G S; Harrison?D A; Sadique?M Z; Grieve?R D; Jahan?R; Tan?J C; Harvey?S E; Bell?D; Bion?J F; Coats?T J; Singer?M; Young?J D; Rowan?K M;
展开▼
作者单位

展开▼
收录信息
原文格式 PDF
正文语种
中图分类放射卫生;
关键词
入库时间 2022-08-18 15:31:14

相似文献

外文文献
中文文献

1. Intravenous immunoglobulin for severe sepsis and septic shock: clinical effectiveness, cost-effectiveness and value of a further randomised controlled trial [J] . Marta O Soares, Nicky J Welton, David A Harrison, Critical care : . 2014,第6期

机译：静脉滴注免疫球蛋白治疗严重败血症和败血性休克的临床疗效，成本效益和进一步随机对照试验的价值
2. An evaluation of the feasibility, cost and value of information of a multicentre randomised controlled trial of intravenous immunoglobulin for sepsis (severe sepsis and septic shock): Incorporating a systematic review, metaanalysis and value of information analysis [J] . Health technology assessment: HTA . 2012,第7期

机译：评估败血症（严重脓毒症和败血性休克）静脉免疫球蛋白的多中心随机对照试验的信息的可行性，成本和价值：纳入系统的综述，荟萃分析和信息分析的价值
3. An evaluation of the feasibility, cost and value of information of a multicentre randomised controlled trial of intravenous immunoglobulin for sepsis (severe sepsis and septic shock): incorporating a systematic review, meta-analysis and value of information analysis [J] . Health technology assessment: HTA . 2012,第7期

机译：一项针对脓毒症（严重脓毒症和败血性休克）的静脉免疫球蛋白多中心随机对照试验的信息可行性，成本和价值评估：纳入系统评价，荟萃分析和信息分析价值
4. A Framework for Patient Data Management and Analysis in Randomised Clinical Trials [C] . Pietro Hiram Guzzi, Tiziana Larussa, Rosarina Vallelunga, IEEE International Conference on Bioinformatics and Biomedicine . 2020

机译：随机临床试验中患者数据管理和分析的框架
5. Hypotensive resuscitation versus standard fluid resuscitation for the management of trauma patients in hemorrhagic shock: The safety phase of a randomized controlled trial. [D] . Morrison, C. Anne. 2009

机译：低血压复苏与标准液体复苏在失血性休克中对创伤患者的处理：一项随机对照试验的安全性阶段。
6. Protocolised Management In Sepsis (ProMISe): a multicentre randomised controlled trial of the clinical effectiveness and cost-effectiveness of early goal-directed protocolised resuscitation for emerging septic shock. [O] . Paul R Mouncey, Tiffany M Osborn, G Sarah Power, -1

机译：脓毒症协议管理（ProMISe）：一项针对新兴脓毒症休克的早期目标导向协议复苏的临床有效性和成本效益的多中心随机对照试验。
7. Protocolised Management In Sepsis (ProMISe): a multicentre randomised controlled trial of the clinical effectiveness and cost-effectiveness of early, goal-directed, protocolised resuscitation for emerging septic shock [O] . Mouncey PR, Osborn TM, Power GS, 2015

机译：脓毒症中的协议化管理（promIse）：一项针对新发感染性休克的早期，目标导向，协议复苏的临床有效性和成本效益的多中心随机对照试验

Protocolised Management In Sepsis (ProMISe): a multicentre, randomised controlled trial of the clinical and cost-effectiveness of early protocolised resuscitation for emerging septic shock

著录项

相似文献

相关主题

期刊订阅